Intersect ENT, Inc. (XENT) has 98 open-market insider trades by 15 insiders since 2014. The most active filer is Lisa D. Earnhardt, CEO & President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Lisa D. Earnhardt | CEOPres | — | 33 | $16.3M | 2019-05-15 |
| Jeryl L. Hilleman | CFO | — | 21 | $10.6M | 2019-05-07 |
| Richard E. Kaufman | COOVP | — | 14 | $4.5M | 2019-01-01 |
| David Aaron Lehman | CLO | — | 4 | $2.1M | 2020-02-03 |
| Robert H. Binney Jr. | CCO | — | 2 | $1.2M | 2020-03-02 |
| Frederic H. Moll | Dir | — | 6 | $948K | 2021-01-19 |
| Amy Wolbeck | VP | — | 3 | $907K | 2016-09-07 |
| Susan P. Stimson | CSO | — | 4 | $906K | 2019-06-13 |
| Gwen R. Carscadden | CPO | — | 1 | $344K | 2021-01-04 |
| Thomas A. West | CEOPres | — | 1 | $323K | 2022-05-13 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Richard A. Meier | CFO | Buy | $39K | 2020-03-17 |
| Thomas A. West | CEO & President | Buy | $323K | 2020-03-17 |
| Richard A. Meier | CFO | Buy | $125K | 2020-03-16 |
| Robert H. Binney Jr. | CCO | Sell | $1.1M | 2019-11-05 |
| Susan P. Stimson | Chief Strategy Officer | Sell | $9K | 2019-06-13 |
| Lisa D. Earnhardt | CEO & President | Sell | $243K |
Companies that share insiders with XENT, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2019-05-15 |
| Susan P. Stimson | CSO | Sell | $146K | 2019-05-10 |
| David Aaron Lehman | CLO | Sell | $297K | 2019-05-06 |
| David Aaron Lehman | CLO | Sell | $297K | 2019-05-06 |
| Susan P. Stimson | CSO | Sell | $388K | 2019-04-29 |
| David Aaron Lehman | CLO | Sell | $297K | 2019-04-29 |
| Susan P. Stimson | CSO | Sell | $80K | 2019-04-23 |
| Lisa D. Earnhardt | CEO & President | Sell | $1.7M | 2019-04-15 |
| Lisa D. Earnhardt | CEO & President | Sell | $841K | 2019-04-15 |
| Susan P. Stimson | CSO | Sell | $291K | 2019-04-10 |